All available tests are listed below. There is further information available for certain tests by clicking on the appropriate link.
|
Name of test |
Reporting time codes |
|
Allan Herndon Dudley syndrome (AHDS) |
1, 2 |
|
Alzheimer disease (familial cases only) |
6 |
|
Androgen insensitivity syndrome (AIS) |
1, 2 |
|
Angelman syndrome (AS) |
4, 5 |
|
Breast/Ovarian cancer (familial cases only)
Referrals only accepted from Clinical Genetics |
1, 2, 6 |
|
Congenital adrenal hyperplasia (21-OH) |
6 |
|
Cystic fibrosis (CF)
Delta F508 and 28 common mutations |
2 |
Urgent newborn screening (IRT) 5 days Rare mutation screening by specific request |
6 |
|
Donohue syndrome |
1, 2 |
|
Dentatorubral-Pallidoluysian atrophy (DRPLA) |
3 |
|
Duchenne/Becker muscular dystrophy
Extended mutation screening by specific request |
3 |
|
Dystonia (DYT1) |
6 |
|
Emery Dreifuss muscular dystrophy, (X-linked) |
1, 2 |
|
Fabry disease |
6 |
|
Facio-scapula-humeral muscular dystrophy |
6 |
|
Familial dysalbuminaemic hyperthyroximaemia
R218H, R218P, L66P common albumin mutations: |
2 |
|
Focal & segmental glomerulosclerosis (FSGS) |
1, 2 |
|
Fragile X syndrome (FraX)
FRAX-E testing by specific request |
3a |
|
Friedreich ataxia (FRDA)
Rare mutation screening by specific request |
3 |
|
Frontotemporal dementia with Parkinsonism
MAPT and PGRN genes |
1, 2 |
|
Gaucher disease |
6 |
|
Gitelman syndrome (GMS) |
1, 2 |
|
Glucorticoid-remediable aldosteronism (GRA) |
3 |
|
Gonadal dysgenesis (SRY gene) |
1, 2 |
|
Haemochromatosis (HFE)
C282Y and H63D common mutations |
2 |
|
Haemophilia A and B (Factor VIII & IX deficiency) |
6 |
|
Hereditary fructose intolerance (HFI) |
1, 2 |
|
Hereditary non-polyposis colon cancer (HNPCC) |
1, 2 |
|
Hereditary motor & sensory neuropathy (HMSN/HNPP)
Deletion/duplication analysis (PMP22 gene only)
Extended mutation screening by specific request only |
6 |
|
Huntington disease
Presymptomatic referral only accepted from Clinical Genetics |
3 |
|
Incontinentia pigmenti (IP)
Common NEMO deletion |
3 |
|
Liddle syndrome |
1, 2 |
|
Medium-chain acyl CoA dehydrogenase deficiency
Common mutation K329E (p.K304E) only |
2 |
|
Metachromatic leukodystrophy |
6 |
|
Mitochondrial disorders MELAS, MERRF, LHON, NARP
Requires completed clinical information sheet |
6 |
|
Multiple endocrine neoplasia Types 1 & 2
Requires completed clinical information sheet |
6 |
|
Myotonic dystrophy (DM1) |
3a |
|
Neurofibromatosis type 2 (NF2) |
6 |
|
Oculopharyneal muscular dystrophy (OPMD) |
6 |
|
Prader-Willi syndrome (PWS) |
4, 5 |
|
Polycystic kidney disease (PKD2) |
1, 2 |
|
Rabson Mendenhall syndrome |
1, 2 |
|
Renal tubular acidosis (dRTA) |
1, 2 |
|
Retinoschisis, X-linked (RS1) |
1, 2 |
|
Sensory neural hearing loss (SNHL)
Common mutations only (Connexin 26/30) |
6 |
|
Spinal bulbar muscular atrophy (Kennedy disease) |
3 |
|
Spinal muscular atrophy (SMA) |
6 |
|
Spinocerebellar ataxia (SCA)
Types 1, 2, 3, 6, 7 & 17 |
3 |
|
Stickler syndrome |
2, 4 |
|
Thyroid hormone resistance (THR) |
1, 2 |
|
Tuberous sclerosis (TSC) |
1, 2 |
|
Uromodulin nephropathy (MCKD2/FJHN) |
1, 2 |
|
Von Hippel-Lindau syndrome |
1, 2 |
|
Confirmation of mutation found on a research basis |
|
Other family members |
8 weeks |
Index case |
2 |
|